Table 1.
MF N=1713 |
Non-MF CTCL N=1518 |
CBCL N=1265 |
|
---|---|---|---|
Male | 975 | 891 | 734 |
Female | 738 | 627 | 531 |
Race | |||
White | 1240 | 1218 | 1096 |
African American | 228 | 152 | 64 |
Asian/Pacific Islander | 108 | 67 | 65 |
Native American/other/unknown | 137 | 81 | 40 |
Marital status | |||
Not married | 488 | 433 | 363 |
Married | 806 | 776 | 720 |
Unknown | 419 | 309 | 182 |
Age | |||
Mean | 57 | 60 | 63 |
Median | 58 | 62 | 64 |
Stage* | |||
Low stage | 1240 | 1012 | |
High stage | 211 | 258 | |
Unstaged | 262 | 248 |
MF-mycosis fungoides; CTCL-cutaneous T-cell lymphoma; CBCL-cutaneous B-cell lymphoma
For MF, low stage = T0–T2, and high stage = T3–T4. For non-MF CTCL, low stage = overall stage 0–II, high stage = overall stage III–IV. CBCL patients were not broken out into high and low staging.